Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
capecitabine (xeloda) (1 trial)
Fluciclovine (Axumin) (1 trial)
fluorouracil (efudex) (1 trial)
irinotecan (Camptosar) (1 trial)
oxaliplatin (eloxatin) (2 trials)
selumetinib (Koselugo) (1 trial)
Colorectal Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Stomach Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (6 total)